Which antibiotic better protects stem cell transplant patients?
NCT ID NCT03850379
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study looked at two common antibiotics, ciprofloxacin and levofloxacin, to see which one better prevents bacterial infections in patients receiving a stem cell transplant. About 308 adults with blood cancers took part. The goal was to find out which drug leads to fewer bloodstream infections in the first 60 days after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEM CELL TRANSPLANT COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford
Detroit, Michigan, 48202, United States
Conditions
Explore the condition pages connected to this study.